Condition: Cardiogenic Shock · Sponsor: Insel Gruppe AG, University Hospital Bern
The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing ECMO or Impella implantation at all included sites. All patients undergoing ECMO and/or IMPELLA implantation will be prospectively registered. Device use is according to the decision of the treating physician and independent of this registry.
This description comes directly from the study's public registry record.
Lukas C Hunziker Munsch, Prof MD · 0041316322111 · lukas.hunziker@insel.ch
Monika Fürholz, MD · 00413163221 11 · monika.fuerholz@insel.ch
Always discuss trial participation with your own doctor first.
| Universitätsspital Basel | Basel, Switzerland | Recruiting |
| Insel Gruppe AG, Inselspital Bern | Bern, Switzerland | Recruiting |
| Luzerner Kantonsspital | Lucerne, Switzerland | Recruiting |
| Kantonsspital Winterthur | Winterthur, Switzerland | Recruiting |
| Stadtspital Treimli | Zurich, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04117230